Chi Van Dang to receive 2024 AACR-Margaret Foti Award

Epigenetic research reveals a potential treatment for CRC and other solid tumors

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new study from researchers at the Johns Hopkins Kimmel Cancer Center and the Chinese Academy of Sciences.

January 17, 2025

Vol.51 No.02

In Brief

Johns Hopkins, Howard University reform collaboration to advance health equity

A collaborative effort to eliminate cancer health disparities among African Americans and other underserved populations in the Washington, DC, area is being reignited at the Johns Hopkins Kimmel Cancer Center and the Howard University Cancer Center.

January 10, 2025

Vol.51 No.01

In Brief

Stephen Baylin and Andrew Feinberg, of Johns Hopkins, win Technion’s Harvey Prize

Stephen BaylinAndrew FeinbergJohns Hopkins University School of Medicine and Johns Hopkins Kimmel Cancer Center researchers Stephen Baylin and Andrew Feinberg were awarded the 2022–2023 Harvey Prize in the field of Science and Technology by the Technion—Israel Institute of Technology.

December 13, 2024

Vol.50 No.46

Clinical Roundup

Scientists identify genes that help cancer cells survive in the bloodstream

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they’ve escaped the low-oxygen regions of a tumor. Each is a potential therapeutic target to stop cancer recurrence, and one—MUC1—is already in clinical trials. The research was published online Sept. 28 in...

November 08, 2024

Vol.50 No.42

Clinical Roundup

Preclinical data suggest WRN inhibitor may be viable treatment for MSI-H tumors

Preclinical data on a development candidate, NTX-452, a novel Werner syndrome helicase inhibitor, was presented at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, by Nimbus Therapeutics.

October 25, 2024

Vol.50 No.40

In Brief

Daniel Drucker awarded 21st AACR-Irving Weinstein Foundation Distinguished Lectureship

Daniel J. Drucker will be awarded the American Association for Cancer Research 21st AACR-Irving Weinstein Foundation Distinguished Lectureship during the 2025 AACR annual meeting, to be held April 25-30 in Chicago, Illinois.

October 11, 2024

Vol.50 No.38

Chi Van Dang to receive 2024 AACR-Margaret Foti Award

YOU MAY BE INTERESTED IN

Epigenetic research reveals a potential treatment for CRC and other solid tumors

Johns Hopkins, Howard University reform collaboration to advance health equity

Stephen Baylin and Andrew Feinberg, of Johns Hopkins, win Technion’s Harvey Prize

Scientists identify genes that help cancer cells survive in the bloodstream

Preclinical data suggest WRN inhibitor may be viable treatment for MSI-H tumors

Daniel Drucker awarded 21st AACR-Irving Weinstein Foundation Distinguished Lectureship

Renew today!

Subscriber content

Never miss an issue!

Login